JSGRX
Price
$27.36
Change
-$0.62 (-2.22%)
Updated
Feb 21 closing price
Net Assets
1.71B
VIGRX
Price
$214.15
Change
-$4.82 (-2.20%)
Updated
Feb 21 closing price
Net Assets
292.14B
Ad is loading...

JSGRX vs VIGRX

Header iconJSGRX vs VIGRX Comparison
Open Charts JSGRX vs VIGRXBanner chart's image
JHancock U.S. Growth R2
Price$27.36
Change-$0.62 (-2.22%)
VolumeN/A
Net Assets1.71B
Vanguard Growth Index Investor
Price$214.15
Change-$4.82 (-2.20%)
VolumeN/A
Net Assets292.14B
JSGRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSGRX vs. VIGRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGRX is a Buy and VIGRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 292B vs. JSGRX (1.71B). VIGRX pays higher dividends than JSGRX: VIGRX (0.43) vs JSGRX (0.00). JSGRX was incepted earlier than VIGRX: JSGRX (10 years) vs VIGRX (32 years). JSGRX is a more actively managed with annual turnover of: 103.00 vs. VIGRX (5.00). JSGRX has a lower initial minimum investment than VIGRX: JSGRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 22.56 vs. JSGRX (9.70). VIGRX return over 5 years is better than : 111.20 vs. JSGRX (34.05).
JSGRXVIGRXJSGRX / VIGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years32 years-
Gain YTD2.2041.354163%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B292B1%
Annual Yield % from dividends0.000.43-
Returns for 1 year9.7022.5643%
Returns for 3 years23.8653.8344%
Returns for 5 years34.05111.2031%
Returns for 10 yearsN/A281.67-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAIR0.35-0.01
-1.49%
Beyond Air
SAP282.99-4.93
-1.71%
SAP SE
BCRX9.21-0.18
-1.92%
BioCryst Pharmaceuticals
ALT6.43-0.20
-3.02%
Altimmune
MASI169.96-7.25
-4.09%
Masimo Corp